Tafazzin Polyclonal Antibody, 50ul Peptide Modification The encoded protein is phosphorylated

The encoded protein is phosphorylated by cyclin A/cyclin-dependent kinase 2 during the S-phase of the cell cycle and possesses both activator and repressor activities

The human FAT10 gene

links TAK1 with TRAF6 and mediates TAK1 activation upon IL-1 stimulation

The long form is expressed in steroidogenic tissues such as testis

and participates in suppressing anti-inflammatory responses and insulin sensitizing

Tafazzin Polyclonal Antibody, 50ul Peptide Modification The encoded protein is phosphorylatedTAZ (tafazzin) encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in TAZ have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is